Common Stock, Value, Issued of Achilles Therapeutics plc from 31 Dec 2020 to 30 Jun 2024

Taxonomy & unit: us-gaap: USD
Description: Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.
Summary: Achilles Therapeutics plc quarterly Common Stock, Value, Issued in USD history and change rate from 31 Dec 2020 to 30 Jun 2024.
Achilles Therapeutics plc Common Stock, Value, Issued for the quarter ending 30 Jun 2024 was $54,000, unchanged year-over-year.
Source SEC data: View on sec.gov

Common Stock, Value, Issued, Quarterly (USD)

Common Stock, Value, Issued, YoY Quarterly Change (%)

Achilles Therapeutics plc Quarterly Common Stock, Value, Issued (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q2 2024	$54,000	$0	0%	30 Jun 2024	6-K	14 Aug 2024	2024	Q2
Q4 2023	$54,000	$0	0%	31 Dec 2023	6-K	14 Aug 2024	2024	Q2
Q2 2023	$54,000			30 Jun 2023	6-K	04 Aug 2023
Q4 2022	$54,000	$0	0%	31 Dec 2022	20-F	04 Apr 2024	2023	FY
Q4 2021	$54,000	+$48,000	+800%	31 Dec 2021	20-F	07 Mar 2023	2022	FY
Q4 2020	$6,000			31 Dec 2020	20-F	01 Mar 2022	2021	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.